← Back to Search

Drug-Eluting Stent

Xience Xpedition DES for Coronary Artery Disease (SHEAR-STENT Trial)

N/A
Waitlist Available
Led By Habib Samady, MD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Summary

This trial will compare two types of stents to see which is better at restoring blood flow and preventing re-narrowing of the vessel.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
In Stent Mean Cross-sectional Area of Neo-intimal Tissue Coverage
Secondary outcome measures
In Stent: Mean Thickness of Strut Coverage at Follow up
In Stent: Plaque Prolapse Post-PCI (In-Stent Mechanistic Endpoint)
In-Stent: Degree of Vascular Straightening Post-percutaneous Coronary Intervention (PCI) (In-Stent Mechanistic Endpoint)
+4 more

Trial Design

2Treatment groups
Active Control
Group I: Xience Xpedition DESActive Control3 Interventions
Xience Xpedition everolimus eluting stent
Group II: Resolute Integrity DESActive Control3 Interventions
Resolute Integrity zotarolimus eluting stent

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,679 Previous Clinical Trials
2,583,580 Total Patients Enrolled
29 Trials studying Coronary Artery Disease
11,260 Patients Enrolled for Coronary Artery Disease
MedtronicIndustry Sponsor
613 Previous Clinical Trials
759,647 Total Patients Enrolled
30 Trials studying Coronary Artery Disease
164,343 Patients Enrolled for Coronary Artery Disease
Habib Samady, MD4.97 ReviewsPrincipal Investigator - Georgia Heart Institute, Northeast Georgia Medical Center
Emory University
2 Previous Clinical Trials
53 Total Patients Enrolled
5Patient Review
They have a wealth of experience and skills, and really care about their patients!
~8 spots leftby Sep 2025